Holen Sie sich die Stockscreener-App
80.14
2.73%
-2.25
Finanzdaten der Mirum Pharmaceuticals Inc-Aktie (MIRM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
10.23%
176.24
|
159.88 | 148.93 | 133.01 | 127.78 |
| Operating Expenses |
76.95%
218.78
|
949.35 | 153.50 | 130.41 | 132.77 |
| Operating Income/Loss |
94.61%
-42.54
|
-789.47 | -4.567 | 2.603 | -4.989 |
| Income/Loss From Continuing Operations Before Tax |
91.70%
-65.54
|
-789.68 | -4.963 | 2.643 | -5.459 |
| Income Tax Expense/Benefit |
255.58%
1.689
|
0.475 | 0.767 | -0.262 | 0.402 |
Net Income/Loss
|
91.49%
-67.23
|
-790.15 | -5.73 | 2.905 | -5.861 |
| Basic Average Shares |
7.69%
63.37
|
58.85 | 0.4402 | 50.64 | 49.73 |
| Diluted Average Shares |
7.69%
63.37
|
58.85 | 0.4402 | 56.99 | 49.73 |
| Basic Earnings Per Share |
92.11%
-1.06
|
-13.43 | -0.12 | 0.06 | -0.12 |
| Diluted Earnings Per Share |
92.11%
-1.06
|
-13.43 | -0.12 | 0.05 | -0.12 |
0.03%
3.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):